Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-25,415
Closed -$1.29M 293
2021
Q3
$1.29M Sell
25,415
-1,000
-4% -$50.6K 0.14% 88
2021
Q2
$1.32M Hold
26,415
0.14% 83
2021
Q1
$1.21M Hold
26,415
0.14% 80
2020
Q4
$1.15M Hold
26,415
0.15% 74
2020
Q3
$1.11M Hold
26,415
0.22% 58
2020
Q2
$1.12M Hold
26,415
0.24% 49
2020
Q1
$1.09M Buy
26,415
+1,000
+4% +$44.8K 0.24% 50
2019
Q4
$1.19M Hold
25,415
0.21% 62
2019
Q3
$1.25M Hold
25,415
0.24% 54
2019
Q2
$1.17M Hold
25,415
0.22% 57
2019
Q1
$1.14M Hold
25,415
0.23% 52
2018
Q4
$1.02M Hold
25,415
0.22% 56
2018
Q3
$1.04M Hold
25,415
0.23% 54
2018
Q2
$1.04M Buy
25,415
+2,915
+13% +$122K 0.26% 54
2018
Q1
$982K Hold
22,500
0.24% 55
2017
Q4
$1.09M Hold
22,500
0.27% 50
2017
Q3
$1.07M Hold
22,500
0.27% 52
2017
Q2
$1.03M Buy
+22,500
New +$1.01M 0.3% 49

Other funds holding BCE

Crescent Grove Advisors's BCE Position: Q4 2021 in Review

Crescent Grove Advisors sold out of BCE (BCE) in Q4 2021, closing a stake of 25,415 shares — an estimated $1.29M sold.

Crescent Grove Advisors first reported a position in BCE in Q2 2017 and held it in 18 quarters. The position peaked at $1.32M in Q2 2021. 606 funds tracked by Wall St. Rank hold BCE as of Q4 2021.

  • Crescent Grove Advisors reported no remaining BCE position as of Q4 2021 after selling out during the quarter.
  • Crescent Grove Advisors sold 25,415 BCE shares in Q4 2021, an estimated $1.29M.
  • Crescent Grove Advisors first reported a position in BCE in Q2 2017 and held it in 18 quarters.
  • Crescent Grove Advisors's BCE position peaked at $1.32M in Q2 2021.
  • 606 funds tracked by Wall St. Rank held BCE as of Q4 2021.

Based on Crescent Grove Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.